Clinical Trials Logo

Clinical Trial Summary

The incidence of atopic dermatitis and type 2 diabetes, respectively, has increased over many years. Novel research shows an association between the two conditions. While this relationship at least in theory can be explained by lifestyle factors, there is reason to believe that other pathophysiological mechanisms are involved. Hence, our hypothesis is that patients with atopic dermatitis are insulin resistant due to their chronic inflammatory state. Insulin resistance might play an unknown part in the increased frequency of type 2 diabetes among patients with atopic dermatitis. In the present project, the investigators aim to measure insulin sensitivity by means of the 'golden standard' hyperinsulinaemic euglycaemic clamp in patients suffering from atopic dermatitis compared to a healthy control group (matched case-control study). The project is a close collaboration between The Department of Dermatology and Allergy and Center for Diabetes Research at Gentofte Hospital.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03003793
Study type Observational
Source University Hospital, Gentofte, Copenhagen
Contact
Status Completed
Phase
Start date November 2015
Completion date December 2017

See also
  Status Clinical Trial Phase
Recruiting NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Completed NCT02284893 - Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone Phase 3
Recruiting NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Recruiting NCT03982381 - SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes Phase 4
Completed NCT04971317 - The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages N/A
Completed NCT04496154 - Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood N/A
Completed NCT04023539 - Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes N/A
Recruiting NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Completed NCT04097600 - A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets Phase 1
Completed NCT03653091 - Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes N/A
Completed NCT04053959 - Artificial Intelligence Assisted Insulin Titration System Phase 4
Recruiting NCT04365400 - TRIgyceride And Glucose Control With Epeleuton in Metabolic Syndrome Patients Phase 2
Recruiting NCT03130244 - Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes N/A
Recruiting NCT04383639 - Cocoa/Carob Polyphenols and Postprandial Changes in Type 2 Diabetes N/A
Recruiting NCT04326192 - Brown Adipose Tissue Activation by Spinal Cord Stimulation N/A
Recruiting NCT01600924 - Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Completed NCT02809365 - FreeStyle Libre- Effect on QOL in Type 2 Diabetes Patients N/A
Not yet recruiting NCT02900417 - Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes N/A
Completed NCT02887898 - Efficacy of Automated Bolus Calculation in Type 2 Diabetes N/A
Completed NCT02235298 - Dapagliflozin Effects on Epicardial Fat Phase 4